Počet záznamů: 1
apolipoprotein C-III
SYS d053305 LBL 02318nz--a2200397n--4500 003 CZ-PrNML 005 20240206162307.5 008 060705-n-ancnnbaba----------||-ana-----d 035 $a (DNLM)D053305 040 $a ABA008 $b cze $f czmesh 072 $a D10. $x 532. $x 091. $x 400. $x 875 072 $a D12. $x 776. $x 070. $x 400. $x 400. $x 875 072 $a D12. $x 776. $x 521. $x 120. $x 400. $x 875 150 $a apolipoprotein C-III $2 czmesh 450 $w i $a apo C-III $i UF 450 $w i $a Apo C-III $i UF 450 $w i $a apo C-III-2 $i UF 450 $w i $a Apo C-III-2 $i UF 450 $w i $a apoC-III $i UF 450 $w i $a ApoC-III $i UF 450 $w i $a apolipoprotein C-III-0 $i UF 450 $w i $a Apolipoprotein C-III-0 $i UF 450 $w i $a apolipoprotein C-III-1 $i UF 450 $w i $a Apolipoprotein C-III-1 $i UF 450 $w i $a apolipoprotein CIII $i UF 450 $w i $a Apolipoprotein CIII $i UF 450 $w i $a sialyl apo C-III $i UF 450 $w i $a Sialyl Apo C-III $i UF 450 $w i $a Sialyl Apolipoprotein C-III $i UF 550 $w g $a apolipoproteiny C $7 upol_us_auth*d001056 680 $i A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS and CHYLOMICRON REMNANTS. Apo C-III, synthesized in the liver, is an inhibitor of LIPOPROTEIN LIPASE. Apo C-III modulates the binding of chylomicron remnants and VLDL to receptors (RECEPTORS, LDL) thus decreases the uptake of triglyceride-rich particles by the liver cells and subsequent degradation. The normal Apo C-III is glycosylated. There are several polymorphic forms with varying amounts of SIALIC ACID (Apo C-III-0, Apo C-III-1, and Apo C-III-2). 688 $a 2007; use APOLIPOPROTEIN C-III (NM) 1979-2006 750 -2
$a Apolipoprotein C-III $2 czmesh 980 $x M 982 $a 1
Počet záznamů: 1